CA2423837C - Detecteur d'analyte in vitro a faible volume et procedes associes - Google Patents

Detecteur d'analyte in vitro a faible volume et procedes associes Download PDF

Info

Publication number: CA2423837C
Authority: CA; Canada
Prior art keywords: sensor; electrode; contact; sample; counter
Prior art date: 1999-11-04
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

CA002423837A

Other languages

English (en)

Other versions

CA2423837A1 (fr

Inventor

Charles T. Liamos

Benjamin J. Feldman

Jeffrey V. Funderburk

Rajesh Krishnan

Phillip J. Plante

Joseph A. Vivolo

Robert Y. Jin

Michael S. Cloud

Fredric C. Colman

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Therasense Inc

Original Assignee

Therasense Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-11-04

Filing date

2000-10-27

Publication date

2007-09-11

1999-11-04 Priority claimed from US09/434,026 external-priority patent/US6616819B1/en

2000-10-27 Application filed by Therasense Inc filed Critical Therasense Inc

2001-05-10 Publication of CA2423837A1 publication Critical patent/CA2423837A1/fr

2007-09-11 Application granted granted Critical

2007-09-11 Publication of CA2423837C publication Critical patent/CA2423837C/fr

2020-10-27 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

239000012491 analyte Substances 0.000 title claims abstract description 107
238000000034 method Methods 0.000 title abstract description 73
238000000338 in vitro Methods 0.000 title description 4
238000003780 insertion Methods 0.000 claims abstract description 38
230000037431 insertion Effects 0.000 claims abstract description 38
238000003869 coulometry Methods 0.000 abstract description 15
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 11
239000008103 glucose Substances 0.000 abstract description 11
210000004369 blood Anatomy 0.000 abstract description 9
239000008280 blood Substances 0.000 abstract description 9
238000004082 amperometric method Methods 0.000 abstract description 6
JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 abstract description 5
239000013060 biological fluid Substances 0.000 abstract description 5
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract description 3
238000004313 potentiometry Methods 0.000 abstract description 3
210000002966 serum Anatomy 0.000 abstract description 3
238000007599 discharging Methods 0.000 abstract description 2
238000012544 monitoring process Methods 0.000 abstract 1
239000000758 substrate Substances 0.000 description 105
238000005259 measurement Methods 0.000 description 94
125000006850 spacer group Chemical group 0.000 description 63
239000000853 adhesive Substances 0.000 description 44
230000001070 adhesive effect Effects 0.000 description 44
239000010408 film Substances 0.000 description 32
239000012992 electron transfer agent Substances 0.000 description 31
238000005868 electrolysis reaction Methods 0.000 description 30
239000010410 layer Substances 0.000 description 30
239000000463 material Substances 0.000 description 28
239000012633 leachable Substances 0.000 description 26
238000009792 diffusion process Methods 0.000 description 24
239000012530 fluid Substances 0.000 description 21
108090000790 Enzymes Proteins 0.000 description 13
102000004190 Enzymes Human genes 0.000 description 13
229940088598 enzyme Drugs 0.000 description 13
230000006870 function Effects 0.000 description 13
238000004519 manufacturing process Methods 0.000 description 11
238000003487 electrochemical reaction Methods 0.000 description 10
238000007639 printing Methods 0.000 description 10
-1 polyethylene Polymers 0.000 description 9
238000006243 chemical reaction Methods 0.000 description 8
230000000875 corresponding effect Effects 0.000 description 8
238000013213 extrapolation Methods 0.000 description 8
239000002594 sorbent Substances 0.000 description 8
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 7
238000003556 assay Methods 0.000 description 7
239000003990 capacitor Substances 0.000 description 7
229920000728 polyester Polymers 0.000 description 7
230000009471 action Effects 0.000 description 6
229910052799 carbon Inorganic materials 0.000 description 6
210000004027 cell Anatomy 0.000 description 6
238000005520 cutting process Methods 0.000 description 6
239000012790 adhesive layer Substances 0.000 description 5
238000004458 analytical method Methods 0.000 description 5
238000013461 design Methods 0.000 description 5
230000036961 partial effect Effects 0.000 description 5
230000037361 pathway Effects 0.000 description 5
229920000642 polymer Polymers 0.000 description 5
229920006254 polymer film Polymers 0.000 description 5
230000008569 process Effects 0.000 description 5
238000012360 testing method Methods 0.000 description 5
RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 4
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
229910021607 Silver chloride Inorganic materials 0.000 description 4
150000001875 compounds Chemical class 0.000 description 4
239000004020 conductor Substances 0.000 description 4
230000007423 decrease Effects 0.000 description 4
239000003814 drug Substances 0.000 description 4
230000000694 effects Effects 0.000 description 4
238000006056 electrooxidation reaction Methods 0.000 description 4
238000010438 heat treatment Methods 0.000 description 4
239000003446 ligand Substances 0.000 description 4
230000003647 oxidation Effects 0.000 description 4
238000007254 oxidation reaction Methods 0.000 description 4
BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
230000002829 reductive effect Effects 0.000 description 4
HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 4
239000000126 substance Substances 0.000 description 4
BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 3
239000002390 adhesive tape Substances 0.000 description 3
230000008901 benefit Effects 0.000 description 3
210000001124 body fluid Anatomy 0.000 description 3
239000010839 body fluid Substances 0.000 description 3
239000003153 chemical reaction reagent Substances 0.000 description 3
239000003795 chemical substances by application Substances 0.000 description 3
230000003247 decreasing effect Effects 0.000 description 3
229940079593 drug Drugs 0.000 description 3
239000007772 electrode material Substances 0.000 description 3
238000012545 processing Methods 0.000 description 3
238000007650 screen-printing Methods 0.000 description 3
239000004094 surface-active agent Substances 0.000 description 3
238000012546 transfer Methods 0.000 description 3
238000007740 vapor deposition Methods 0.000 description 3
238000013022 venting Methods 0.000 description 3
239000002699 waste material Substances 0.000 description 3
BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
108010050375 Glucose 1-Dehydrogenase Proteins 0.000 description 2
108010015776 Glucose oxidase Proteins 0.000 description 2
239000004366 Glucose oxidase Substances 0.000 description 2
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
108010073450 Lactate 2-monooxygenase Proteins 0.000 description 2
KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
239000004698 Polyethylene Substances 0.000 description 2
LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 2
206010052428 Wound Diseases 0.000 description 2
208000027418 Wounds and injury Diseases 0.000 description 2
150000001252 acrylic acid derivatives Chemical class 0.000 description 2
229920006397 acrylic thermoplastic Polymers 0.000 description 2
229940072107 ascorbate Drugs 0.000 description 2
235000010323 ascorbic acid Nutrition 0.000 description 2
239000011668 ascorbic acid Substances 0.000 description 2
229920002678 cellulose Polymers 0.000 description 2
239000001913 cellulose Substances 0.000 description 2
230000008859 change Effects 0.000 description 2
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
239000011248 coating agent Substances 0.000 description 2
238000000576 coating method Methods 0.000 description 2
239000011231 conductive filler Substances 0.000 description 2
230000001276 controlling effect Effects 0.000 description 2
CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
238000001514 detection method Methods 0.000 description 2
239000003989 dielectric material Substances 0.000 description 2
229920001971 elastomer Polymers 0.000 description 2
210000003722 extracellular fluid Anatomy 0.000 description 2
239000000945 filler Substances 0.000 description 2
229940116332 glucose oxidase Drugs 0.000 description 2
235000019420 glucose oxidase Nutrition 0.000 description 2
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
229910052737 gold Inorganic materials 0.000 description 2
239000010931 gold Substances 0.000 description 2
238000007373 indentation Methods 0.000 description 2
239000011810 insulating material Substances 0.000 description 2
238000000691 measurement method Methods 0.000 description 2
229910052751 metal Inorganic materials 0.000 description 2
239000002184 metal Substances 0.000 description 2
239000012811 non-conductive material Substances 0.000 description 2
229960005489 paracetamol Drugs 0.000 description 2
229910052697 platinum Inorganic materials 0.000 description 2
229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
229920000573 polyethylene Polymers 0.000 description 2
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
MMXZSJMASHPLLR-UHFFFAOYSA-N pyrroloquinoline quinone Chemical compound C12=C(C(O)=O)C=C(C(O)=O)N=C2C(=O)C(=O)C2=C1NC(C(=O)O)=C2 MMXZSJMASHPLLR-UHFFFAOYSA-N 0.000 description 2
238000006722 reduction reaction Methods 0.000 description 2
239000005060 rubber Substances 0.000 description 2
WOCIAKWEIIZHES-UHFFFAOYSA-N ruthenium(iv) oxide Chemical compound O=[Ru]=O WOCIAKWEIIZHES-UHFFFAOYSA-N 0.000 description 2
229910052709 silver Inorganic materials 0.000 description 2
239000004332 silver Substances 0.000 description 2
238000003860 storage Methods 0.000 description 2
ISXSCDLOGDJUNJ-UHFFFAOYSA-N tert-butyl prop-2-enoate Chemical compound CC(C)(C)OC(=O)C=C ISXSCDLOGDJUNJ-UHFFFAOYSA-N 0.000 description 2
ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
239000010409 thin film Substances 0.000 description 2
238000010023 transfer printing Methods 0.000 description 2
150000003623 transition metal compounds Chemical group 0.000 description 2
150000003673 urethanes Chemical class 0.000 description 2
108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
KMRPQHUALQQSPI-UHFFFAOYSA-N 1-methyl-2-(1-methylimidazol-2-yl)imidazole Chemical compound CN1C=CN=C1C1=NC=CN1C KMRPQHUALQQSPI-UHFFFAOYSA-N 0.000 description 1
101100230376 Acetivibrio thermocellus (strain ATCC 27405 / DSM 1237 / JCM 9322 / NBRC 103400 / NCIMB 10682 / NRRL B-4536 / VPI 7372) celI gene Proteins 0.000 description 1
239000004382 Amylase Substances 0.000 description 1
102000013142 Amylases Human genes 0.000 description 1
108010065511 Amylases Proteins 0.000 description 1
229920000049 Carbon (fiber) Polymers 0.000 description 1
102000011022 Chorionic Gonadotropin Human genes 0.000 description 1
108010062540 Chorionic Gonadotropin Proteins 0.000 description 1
208000034656 Contusions Diseases 0.000 description 1
102000004420 Creatine Kinase Human genes 0.000 description 1
108010042126 Creatine kinase Proteins 0.000 description 1
239000004971 Cross linker Substances 0.000 description 1
WDJUZGPOPHTGOT-OAXVISGBSA-N Digitoxin Natural products O([C@H]1[C@@H](C)O[C@@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@@](C)([C@H](C6=CC(=O)OC6)CC5)CC4)CC3)CC2)C[C@H]1O)[C@H]1O[C@@H](C)[C@H](O[C@H]2O[C@@H](C)[C@@H](O)[C@@H](O)C2)[C@@H](O)C1 WDJUZGPOPHTGOT-OAXVISGBSA-N 0.000 description 1
LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 description 1
239000004593 Epoxy Substances 0.000 description 1
CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
229930182566 Gentamicin Natural products 0.000 description 1
208000013016 Hypoglycemia Diseases 0.000 description 1
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
239000000020 Nitrocellulose Substances 0.000 description 1
239000004677 Nylon Substances 0.000 description 1
239000004820 Pressure-sensitive adhesive Substances 0.000 description 1
108010072866 Prostate-Specific Antigen Proteins 0.000 description 1
102100038358 Prostate-specific antigen Human genes 0.000 description 1
102100027378 Prothrombin Human genes 0.000 description 1
108010094028 Prothrombin Proteins 0.000 description 1
KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 1
238000003854 Surface Print Methods 0.000 description 1
102000011923 Thyrotropin Human genes 0.000 description 1
108010061174 Thyrotropin Proteins 0.000 description 1
108090001027 Troponin Proteins 0.000 description 1
108010059993 Vancomycin Proteins 0.000 description 1
OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
229960004373 acetylcholine Drugs 0.000 description 1
239000002313 adhesive film Substances 0.000 description 1
235000019418 amylase Nutrition 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
230000017531 blood circulation Effects 0.000 description 1
208000034526 bruise Diseases 0.000 description 1
239000000872 buffer Substances 0.000 description 1
238000004364 calculation method Methods 0.000 description 1
238000011088 calibration curve Methods 0.000 description 1
229940075397 calomel Drugs 0.000 description 1
239000004917 carbon fiber Substances 0.000 description 1
235000012000 cholesterol Nutrition 0.000 description 1
229940107161 cholesterol Drugs 0.000 description 1
229940015047 chorionic gonadotropin Drugs 0.000 description 1
238000000970 chrono-amperometry Methods 0.000 description 1
238000004769 chrono-potentiometry Methods 0.000 description 1
150000001869 cobalt compounds Chemical class 0.000 description 1
230000000295 complement effect Effects 0.000 description 1
239000002131 composite material Substances 0.000 description 1
150000004696 coordination complex Chemical class 0.000 description 1
230000002596 correlated effect Effects 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
229960003624 creatine Drugs 0.000 description 1
239000006046 creatine Substances 0.000 description 1
206010012601 diabetes mellitus Diseases 0.000 description 1
229960000648 digitoxin Drugs 0.000 description 1
WDJUZGPOPHTGOT-XUDUSOBPSA-N digitoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)CC5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O WDJUZGPOPHTGOT-XUDUSOBPSA-N 0.000 description 1
229960005156 digoxin Drugs 0.000 description 1
LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 description 1
LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 description 1
ZOMNIUBKTOKEHS-UHFFFAOYSA-L dimercury dichloride Chemical compound Cl[Hg][Hg]Cl ZOMNIUBKTOKEHS-UHFFFAOYSA-L 0.000 description 1
230000002500 effect on skin Effects 0.000 description 1
238000000840 electrochemical analysis Methods 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
229920006334 epoxy coating Polymers 0.000 description 1
125000003700 epoxy group Chemical group 0.000 description 1
KTWOOEGAPBSYNW-UHFFFAOYSA-N ferrocene Chemical compound [Fe+2].C=1C=C[CH-]C=1.C=1C=C[CH-]C=1 KTWOOEGAPBSYNW-UHFFFAOYSA-N 0.000 description 1
IXZISFNWUWKBOM-ARQDHWQXSA-N fructosamine Chemical compound NC[C@@]1(O)OC[C@@H](O)[C@@H](O)[C@@H]1O IXZISFNWUWKBOM-ARQDHWQXSA-N 0.000 description 1
238000007429 general method Methods 0.000 description 1
229960002518 gentamicin Drugs 0.000 description 1
108010054770 glucose dehydrogenase (pyrroloquinoline-quinone) Proteins 0.000 description 1
125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
229910002804 graphite Inorganic materials 0.000 description 1
239000010439 graphite Substances 0.000 description 1
239000000122 growth hormone Substances 0.000 description 1
239000005556 hormone Substances 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
201000001421 hyperglycemia Diseases 0.000 description 1
150000002460 imidazoles Chemical class 0.000 description 1
125000002883 imidazolyl group Chemical group 0.000 description 1
230000003100 immobilizing effect Effects 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
238000007641 inkjet printing Methods 0.000 description 1
229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 description 1
229910052742 iron Inorganic materials 0.000 description 1
238000005304 joining Methods 0.000 description 1
150000002576 ketones Chemical class 0.000 description 1
238000012886 linear function Methods 0.000 description 1
239000007788 liquid Substances 0.000 description 1
238000007620 mathematical function Methods 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
239000012528 membrane Substances 0.000 description 1
VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
229920001220 nitrocellulos Polymers 0.000 description 1
229910017464 nitrogen compound Inorganic materials 0.000 description 1
229920001778 nylon Polymers 0.000 description 1
229920000620 organic polymer Polymers 0.000 description 1
125000002524 organometallic group Chemical group 0.000 description 1
229910052762 osmium Inorganic materials 0.000 description 1
SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 description 1
230000001590 oxidative effect Effects 0.000 description 1
230000008533 pain sensitivity Effects 0.000 description 1
238000010422 painting Methods 0.000 description 1
229910052763 palladium Inorganic materials 0.000 description 1
230000035515 penetration Effects 0.000 description 1
150000002978 peroxides Chemical class 0.000 description 1
239000004033 plastic Substances 0.000 description 1
229920003023 plastic Polymers 0.000 description 1
229920000515 polycarbonate Polymers 0.000 description 1
239000004417 polycarbonate Substances 0.000 description 1
229920000647 polyepoxide Polymers 0.000 description 1
229920000139 polyethylene terephthalate Polymers 0.000 description 1
239000005020 polyethylene terephthalate Substances 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
238000003825 pressing Methods 0.000 description 1
229940039716 prothrombin Drugs 0.000 description 1
238000011002 quantification Methods 0.000 description 1
230000009467 reduction Effects 0.000 description 1
230000027756 respiratory electron transport chain Effects 0.000 description 1
230000004044 response Effects 0.000 description 1
230000000717 retained effect Effects 0.000 description 1
229910052707 ruthenium Inorganic materials 0.000 description 1
210000003296 saliva Anatomy 0.000 description 1
238000005070 sampling Methods 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
238000000926 separation method Methods 0.000 description 1
ADZWSOLPGZMUMY-UHFFFAOYSA-M silver bromide Chemical compound [Ag]Br ADZWSOLPGZMUMY-UHFFFAOYSA-M 0.000 description 1
239000002356 single layer Substances 0.000 description 1
239000007787 solid Substances 0.000 description 1
238000005507 spraying Methods 0.000 description 1
210000004243 sweat Anatomy 0.000 description 1
210000001138 tear Anatomy 0.000 description 1
238000012956 testing procedure Methods 0.000 description 1
229960000278 theophylline Drugs 0.000 description 1
229910052723 transition metal Inorganic materials 0.000 description 1
150000003624 transition metals Chemical class 0.000 description 1
210000000689 upper leg Anatomy 0.000 description 1
238000011144 upstream manufacturing Methods 0.000 description 1
210000002700 urine Anatomy 0.000 description 1
229960003165 vancomycin Drugs 0.000 description 1
MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 description 1
MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 1
238000012795 verification Methods 0.000 description 1
125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
229920002554 vinyl polymer Polymers 0.000 description 1
230000000007 visual effect Effects 0.000 description 1
PJVWKTKQMONHTI-UHFFFAOYSA-N warfarin Chemical compound OC=1C2=CC=CC=C2OC(=O)C=1C(CC(=O)C)C1=CC=CC=C1 PJVWKTKQMONHTI-UHFFFAOYSA-N 0.000 description 1
229960005080 warfarin Drugs 0.000 description 1
239000001993 wax Substances 0.000 description 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
- G01N27/3271—Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
- G01N27/3272—Test elements therefor, i.e. disposable laminated substrates with electrodes, reagent and channels

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Physics & Mathematics (AREA)
Biochemistry (AREA)
Hematology (AREA)
Chemical Kinetics & Catalysis (AREA)
Electrochemistry (AREA)
Biophysics (AREA)
Analytical Chemistry (AREA)
Molecular Biology (AREA)
General Health & Medical Sciences (AREA)
General Physics & Mathematics (AREA)
Immunology (AREA)
Pathology (AREA)
Investigating Or Analysing Biological Materials (AREA)
Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

CA002423837A 1999-11-04 2000-10-27 Detecteur d'analyte in vitro a faible volume et procedes associes Expired - Fee Related CA2423837C (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US09/434,026		1999-11-04
US09/434,026 US6616819B1 (en)	1999-11-04	1999-11-04	Small volume in vitro analyte sensor and methods
CA002358993A CA2358993C (fr)	1999-11-04	2000-10-27	Detecteur d'analyte in vitro de petit volume et procedes associes

Related Parent Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002358993A Division CA2358993C (fr)	1999-11-04	2000-10-27	Detecteur d'analyte in vitro de petit volume et procedes associes

Publications (2)

Publication Number	Publication Date
CA2423837A1 CA2423837A1 (fr)	2001-05-10
CA2423837C true CA2423837C (fr)	2007-09-11

Family

ID=25682753

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002423837A Expired - Fee Related CA2423837C (fr)	1999-11-04	2000-10-27	Detecteur d'analyte in vitro a faible volume et procedes associes

Country Status (1)

Country	Link
CA (1)	CA2423837C (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8026104B2 (en)	2006-10-24	2011-09-27	Bayer Healthcare Llc	Transient decay amperometry
US8404100B2 (en)	2005-09-30	2013-03-26	Bayer Healthcare Llc	Gated voltammetry
US8425757B2 (en)	2005-07-20	2013-04-23	Bayer Healthcare Llc	Gated amperometry
US9410917B2 (en)	2004-02-06	2016-08-09	Ascensia Diabetes Care Holdings Ag	Method of using a biosensor

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MX2007002060A (es)	2004-08-20	2007-04-24	Bayer Healthcare Llc	Ensamblaje conector de contactos para un instrumento de suministro de sensores.
WO2009076302A1 (fr)	2007-12-10	2009-06-18	Bayer Healthcare Llc	Marqueurs de contrôle pour la détection automatique d'une solution de contrôle et procédés d'utilisation
WO2015106331A1 (fr) *	2014-01-16	2015-07-23	Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of National Defence	Appareil et procédé de dosage à écoulement latéral, et capteur associé

2000
- 2000-10-27 CA CA002423837A patent/CA2423837C/fr not_active Expired - Fee Related

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9410917B2 (en)	2004-02-06	2016-08-09	Ascensia Diabetes Care Holdings Ag	Method of using a biosensor
US8425757B2 (en)	2005-07-20	2013-04-23	Bayer Healthcare Llc	Gated amperometry
US8877035B2 (en)	2005-07-20	2014-11-04	Bayer Healthcare Llc	Gated amperometry methods
US8404100B2 (en)	2005-09-30	2013-03-26	Bayer Healthcare Llc	Gated voltammetry
US8647489B2 (en)	2005-09-30	2014-02-11	Bayer Healthcare Llc	Gated voltammetry devices
US9110013B2 (en)	2005-09-30	2015-08-18	Bayer Healthcare Llc	Gated voltammetry methods
US8026104B2 (en)	2006-10-24	2011-09-27	Bayer Healthcare Llc	Transient decay amperometry
US8470604B2 (en)	2006-10-24	2013-06-25	Bayer Healthcare Llc	Transient decay amperometry
US9005527B2 (en)	2006-10-24	2015-04-14	Bayer Healthcare Llc	Transient decay amperometry biosensors

Also Published As

Publication number	Publication date
CA2423837A1 (fr)	2001-05-10

Legal Events

Date	Code	Title	Description
2005-06-29	EEER	Examination request
2020-12-08	MKLA	Lapsed	Effective date: 20201027

Publication	Publication Date	Title
CA2358993C (fr)	2005-08-02	Detecteur d'analyte in vitro de petit volume et procedes associes
US8186044B2 (en)	2012-05-29	Method of manufacturing small volume in vitro analyte sensors
US8532731B2 (en)	2013-09-10	Methods of determining analyte concentration
US20080021295A1 (en)	2008-01-24	Sample Acquisition and Analyte Measurement Device
CA2423837C (fr)	2007-09-11	Detecteur d'analyte in vitro a faible volume et procedes associes